Screening and Monitoring of Cancer (New Horizons in Oncology, vol 4) pp 440 £44.50 ISBN 0 471 90483 X Chichester: John Wiley 1985 This book is fourth in a series of volumes entitled 'New Horizons in Oncology', presided over by Basil Stoll, one of medicine's more prolific editors. Stoll has put together an impressive book, obtaining the services of some of the most experienced oncologists in the world.
Part 1 of the book deals with techniques of screening and includes various chapters on general aspects of cytodiagnosis, tumour markers and imaging techniques. I was disappointed by the chapter on cytodiagnosis which deals with the topic in a superficial manner. The chapter on isotopic imaging is more comprehensive, although I was surprised by the absence of any reference to the pioneering work of Galasko in skeletal scanning. The chapter on magnetic resonance is outstanding.
Part 2 is concerned with screening at specific sites. This section contains lucid but necessarily somewhat brief accounts of the philosophy and practice of screening for ocult malignant disease of the lung, breast, cervix, stomach and large intestine. The level of enthusiasm varies according to the feelings of the respective authors. In general the reader is left to make up his/her own mind on the evidence presented.
Part 3 of the volume discusses 'monitoring' techniques. In his preface, Stoll explains the term. He includes under the title specific investigations necessary for staging patients with apparently early cancers, and those used to assess progress after treatment. This, perhaps, is the most novel part of the book and, although repetition is frequent, makes excellent reading. This is an imaginative book, full of useful information on a topical subject. This book is the result of a symposium on hepatocyte injury and death. There are 36 separate contributions and these vary between those which are generally informative to those which are more specific, with the emphasis on mechanisms.
IAN BURN
The subject of this book is very timely and the coverage of the subject is excellent. There are contributions on all the major areas relating to cellular injury, ranging from the role of reactive metabolites in liver injury, the roles of phospholipase C, cell surface changes, the importance of cytoskeleton and immunologically mediated cell injury, with particular emphasis on the role of calcium in cell injury. The contributions span clinical, pathological, biochemical and toxicological aspects and will be of interest to workers in all these fields.
The contributions are mostly well referenced and up to date. Clearly some of the points raised may be contentious, as with any publication covering a rapidly changing field. For example, I would not support the view expressed in Chapter 4 that cytochrome P-450 is a toxicologically protective enzyme whereas cytochrome P-448 is not. There are several well known examples of compounds (carbon tetrachloride, bromobenzene, acetylhydrazine and paracetamol) which are hepatotoxic due to metabolic activation by cytochrome P-450 rather than cytochrome P-448, which may indeed catalyse detoxication pathways. The relative importance of detoxication and activation pathways catalysed by cytochrome P-450, P-448 and other enzymes is influenced by many factors, including chemical structure and species.
The book is well produced and illustrated and has been rapidly published (10 months after the symposium). I would strongly recommend it to those interested in the mechanisms of cell death for a comprehensive view of current thinking in this area.
JOHN A TIMBRELL Lecturer in Toxicology School of Pharmacy, London Leukaemias and Lymphomas P H Wiernik (ed) pp 287 £36 ISBN 0-443-08345-2 Edinburgh: Churchill Livingstone 1985 This book has failed to present any new ideas or thoughts to interest those involved in the management of patients with either leukaemia or lymphoma. The five of ten chapters which are directed towards the treatment of these disorders offer comprehensive but dull lists of chemotherapeutic cocktails which read like a telephone directory. It would have been more useful had the authors selected their information, directed attention to the principles of chemotherapy and discussed more rationally some future approaches. In the chapter on non-Hodgkin's lymphoma in adults, the excessive use of acronyms created a code which I struggled to decipher.
The most serious omission is the failure to dedicate a chapter to myelodysplasia, a topic of wide haemato-oncological interest. There are also errors: it is a mistake to suggest that indomethacin produces an irreversible defect in platelet aggregation that lasts for the life of the platelet, and a considerable error to indicate that Von Willebrand's disease is an intrinsic platelet defect. In a book that I otherwise found to be very disappointing only the excellent chapter on Hodgkin's disease stood out. This is a much-needed book about this heterogeneous group of disorders and it certainly is the most comprehensive and up-to-date text on the subject. The authors are distinguished geneticists from South America who have contributed to the literature on the ectodermal dysplasias both descriptively and from a genetic angle. The book begins with a general chapter on definition and classification which owes much to the work of Dr Opitz, with whom the senior author worked and who provided the foreword. The major part of the book is concerned with description of the various ectodermal dysplasias, dividing them into those where hair,
